Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma
The genetic approach of pheochromocytomas and paragangliomas has changed in the last two decades. Nowadays, we know that more than 40% of patients have a germline mutation in one of the susceptibility genes identified to date. Our aim is to underline how genetic diagnosis by next-generation sequenci...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2020/3671396 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832547741368057856 |
|---|---|
| author | Giuseppina De Filpo Elisa Contini Viola Serio Andrea Valeri Massimiliano Chetta Daniele Guasti Daniele Bani Massimo Mannelli Elena Rapizzi Michaela Luconi Mario Maggi Tonino Ercolino Letizia Canu |
| author_facet | Giuseppina De Filpo Elisa Contini Viola Serio Andrea Valeri Massimiliano Chetta Daniele Guasti Daniele Bani Massimo Mannelli Elena Rapizzi Michaela Luconi Mario Maggi Tonino Ercolino Letizia Canu |
| author_sort | Giuseppina De Filpo |
| collection | DOAJ |
| description | The genetic approach of pheochromocytomas and paragangliomas has changed in the last two decades. Nowadays, we know that more than 40% of patients have a germline mutation in one of the susceptibility genes identified to date. Our aim is to underline how genetic diagnosis by next-generation sequencing (NGS) can improve the management of patients affected by pheochromocytomas and paragangliomas in our routine diagnostic screening. We reported a case presentation and next-generation sequencing analysis supported by in silico studies and evaluation of mitochondrial status in KIF1Bβ tissue. A 46-year-old male affected by a left secreting pheochromocytoma underwent surgery in 2017. After surgery, the normetanephrine levels decreased very slowly and a suspected abdominal lymph node was detected. We found a novel germline KIF1Bβ gene mutation, c.4052C > T, p. Pro1351Leu associated with tumor loss of heterozygosity, and resulted likely-pathogenetic by in silico studies. This mutation was also associated with an increased number of mitochondria through the electron microscopy compared with wild-type tissues as suggestive for mitochondria neoformation compensatory to the mitochondrial autophagic figures observed. Our results underline the usefulness of next-generation sequencing in the presence of multiple tumor predisposition genes and how, at the same time, its use may result challenging for the clinicians. To date, performing the genetic analysis according to the latest Consensus Statement is mandatory in patients affected by PHEO/PGL. |
| format | Article |
| id | doaj-art-d8fc0e09e87348c19b751470b08d7b7a |
| institution | Kabale University |
| issn | 1687-8337 1687-8345 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-d8fc0e09e87348c19b751470b08d7b7a2025-02-03T06:43:45ZengWileyInternational Journal of Endocrinology1687-83371687-83452020-01-01202010.1155/2020/36713963671396Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with PheochromocytomaGiuseppina De Filpo0Elisa Contini1Viola Serio2Andrea Valeri3Massimiliano Chetta4Daniele Guasti5Daniele Bani6Massimo Mannelli7Elena Rapizzi8Michaela Luconi9Mario Maggi10Tonino Ercolino11Letizia Canu12Dept. of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, ItalyCenter of Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence, Florence, ItalyDept. of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, ItalyGeneral and Surgical Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, ItalyA.O.R.N. Cardarelli, Medical Genetics, Pad. Y, Naples, ItalyDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyDept. of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, ItalyDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyDept. of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, ItalyDept. of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, ItalyEndocrinology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, ItalyDept. of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, ItalyThe genetic approach of pheochromocytomas and paragangliomas has changed in the last two decades. Nowadays, we know that more than 40% of patients have a germline mutation in one of the susceptibility genes identified to date. Our aim is to underline how genetic diagnosis by next-generation sequencing (NGS) can improve the management of patients affected by pheochromocytomas and paragangliomas in our routine diagnostic screening. We reported a case presentation and next-generation sequencing analysis supported by in silico studies and evaluation of mitochondrial status in KIF1Bβ tissue. A 46-year-old male affected by a left secreting pheochromocytoma underwent surgery in 2017. After surgery, the normetanephrine levels decreased very slowly and a suspected abdominal lymph node was detected. We found a novel germline KIF1Bβ gene mutation, c.4052C > T, p. Pro1351Leu associated with tumor loss of heterozygosity, and resulted likely-pathogenetic by in silico studies. This mutation was also associated with an increased number of mitochondria through the electron microscopy compared with wild-type tissues as suggestive for mitochondria neoformation compensatory to the mitochondrial autophagic figures observed. Our results underline the usefulness of next-generation sequencing in the presence of multiple tumor predisposition genes and how, at the same time, its use may result challenging for the clinicians. To date, performing the genetic analysis according to the latest Consensus Statement is mandatory in patients affected by PHEO/PGL.http://dx.doi.org/10.1155/2020/3671396 |
| spellingShingle | Giuseppina De Filpo Elisa Contini Viola Serio Andrea Valeri Massimiliano Chetta Daniele Guasti Daniele Bani Massimo Mannelli Elena Rapizzi Michaela Luconi Mario Maggi Tonino Ercolino Letizia Canu Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma International Journal of Endocrinology |
| title | Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma |
| title_full | Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma |
| title_fullStr | Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma |
| title_full_unstemmed | Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma |
| title_short | Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma |
| title_sort | germline mutation in kif1bβ gene associated with loss of heterozygosity usefulness of next generation sequencing in the genetic screening of patients with pheochromocytoma |
| url | http://dx.doi.org/10.1155/2020/3671396 |
| work_keys_str_mv | AT giuseppinadefilpo germlinemutationinkif1bbgeneassociatedwithlossofheterozygosityusefulnessofnextgenerationsequencinginthegeneticscreeningofpatientswithpheochromocytoma AT elisacontini germlinemutationinkif1bbgeneassociatedwithlossofheterozygosityusefulnessofnextgenerationsequencinginthegeneticscreeningofpatientswithpheochromocytoma AT violaserio germlinemutationinkif1bbgeneassociatedwithlossofheterozygosityusefulnessofnextgenerationsequencinginthegeneticscreeningofpatientswithpheochromocytoma AT andreavaleri germlinemutationinkif1bbgeneassociatedwithlossofheterozygosityusefulnessofnextgenerationsequencinginthegeneticscreeningofpatientswithpheochromocytoma AT massimilianochetta germlinemutationinkif1bbgeneassociatedwithlossofheterozygosityusefulnessofnextgenerationsequencinginthegeneticscreeningofpatientswithpheochromocytoma AT danieleguasti germlinemutationinkif1bbgeneassociatedwithlossofheterozygosityusefulnessofnextgenerationsequencinginthegeneticscreeningofpatientswithpheochromocytoma AT danielebani germlinemutationinkif1bbgeneassociatedwithlossofheterozygosityusefulnessofnextgenerationsequencinginthegeneticscreeningofpatientswithpheochromocytoma AT massimomannelli germlinemutationinkif1bbgeneassociatedwithlossofheterozygosityusefulnessofnextgenerationsequencinginthegeneticscreeningofpatientswithpheochromocytoma AT elenarapizzi germlinemutationinkif1bbgeneassociatedwithlossofheterozygosityusefulnessofnextgenerationsequencinginthegeneticscreeningofpatientswithpheochromocytoma AT michaelaluconi germlinemutationinkif1bbgeneassociatedwithlossofheterozygosityusefulnessofnextgenerationsequencinginthegeneticscreeningofpatientswithpheochromocytoma AT mariomaggi germlinemutationinkif1bbgeneassociatedwithlossofheterozygosityusefulnessofnextgenerationsequencinginthegeneticscreeningofpatientswithpheochromocytoma AT toninoercolino germlinemutationinkif1bbgeneassociatedwithlossofheterozygosityusefulnessofnextgenerationsequencinginthegeneticscreeningofpatientswithpheochromocytoma AT letiziacanu germlinemutationinkif1bbgeneassociatedwithlossofheterozygosityusefulnessofnextgenerationsequencinginthegeneticscreeningofpatientswithpheochromocytoma |